BOSTON, Dec. 11, 2019 /PRNewswire/ -- Haemonetics
Corporation (NYSE: HAE), a global medical technology company
focused on delivering innovative hematology solutions to drive
better patient outcomes, today opened its new global headquarters
in Boston. The new space supports
Haemonetics' work to build a collaborative, performance-driven
culture, bringing together the Company's corporate and commercial
teams side by side with its research and development (R&D)
organization in a contemporary environment.
"Relocating our headquarters to Boston is an important step in Haemonetics'
transformation," said Chris Simon,
President and CEO of Haemonetics. "Our new downtown location in
close proximity to the medical, technology and higher education
communities that are driving the future of our industry will help
foster innovation and collaboration to improve the quality of care
for the patients, donors and healthcare providers who depend on our
technologies."
The new Boston location
occupies over 62,000 square feet across four floors at 125 Summer
Street, a modern, LEED Gold and Energy Star certified office tower.
This relocation enables the Company to right-size its footprint by
moving from its former location on a multiacre campus in
Braintree, Massachusetts, to a
sustainable and efficient space in a contemporary facility with
access to public transportation and major roadways. The building is
centrally located near South Station and offers services such as an
employee gym and bike maintenance and storage.
The Haemonetics office layout maximizes exposure to natural
light and features dedicated state-of-the-art lab space for the
Company's R&D teams. The open concept office gives employees
personal workspaces with electronically controlled sit-stand desks
and updated technology, several types of collaboration spaces, a
wellness room and a café with a variety of amenities including
snacks, flavored waters and rotating on-tap beverages like cold
brew coffee.
"We are thrilled to welcome Haemonetics to Boston, as attracting innovative companies
that demonstrate high performance and aspire to solve tough
challenges in technology and healthcare will help us drive economic
growth in the region," said James E.
Rooney, President and CEO of the Greater Boston Chamber of Commerce.
"Haemonetics' addition to our diverse and collaborative business
community further solidifies the city's status as a major
innovation and med tech hub."
Founded in 1971 in Massachusetts, Haemonetics has a global
presence, conducting business in more than 90 countries. The
Company has approximately 3,000 global employees, with more than
200 based in Boston.
About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company
dedicated to providing a suite of innovative hematology products
and solutions for customers, to help them improve patient care and
reduce the cost of healthcare. Our technology addresses important
medical markets: blood and plasma component collection, the
surgical suite and hospital transfusion services. To learn more
about Haemonetics, visit www.haemonetics.com
Investor
Contact:
|
Media
Contact:
|
Olga
Guyette, Director-Investor
Relations
|
Carla Burigatto,
VP-Global Communications
|
(781)
356-9763
|
(781)
348-7263
|
olga.guyette@haemonetics.com
|
carla.burigatto@haemonetics.com
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/haemonetics-opens-new-corporate-headquarters-in-downtown-boston-300973509.html
SOURCE Haemonetics Corporation